SPC-5001 | Interleukin Related interleukin-related.com

Product Name :
SPC-5001

Search keywords :
SPC5001

drugId :
null

Target Vo:
Proprotein convertase subtilisin kexin type 9

Target Vo Short Name :
PCSK9

Moa_Name:
Proprotein convertase subtilisin kexin type 9 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
F. Hoffmann-La Roche Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Hypercholesterolemia

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tusamitamab ravtansine supplier
Anti-Mouse CTLA-4 Antibody (9D9) Autophagy
SOX1 Antibody: SOX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to SOX1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts